OMB
First Class Captain
- Joined
- Dec 27, 2010
- Runs
- 4,288
India will carry out a deeper review of post-vaccination side effects from the AstraZeneca
This comes in the wake of Denmark, Norway, Iceland and Thailand temporarily halting vaccination with the drug, after isolated
reports of recipients developing blood clots.
"We are looking at all the adverse events, particularly serious adverse events like deaths and hospitalisation. We will come back if we find anything of concern," N.K. Arora, a member of National Task Force on Covid-19, told news agency AFP.
Arora said there was "no immediate issue of concern as number of adverse events (in India) is very, very low. "We are relooking at these to see if there was any issue of blood clotting."
8 States accounted for 74% of the doses, with Uttar Pradesh topping the list with more than 3.3 lakh vaccine doses. Cumulatively, over 2.82 crore doses have been administered so far. India has been using Covishield and Bharat Biotech's Covaxin for its mass vaccination programme.
India’s total active caseload stands at 2.02 lakh . 24,882 new cases were registered in the last 24 hours. India on Saturday recorded 24,882 fresh Covid-19 infections, the highest so far this year, which took the caseload to 1,13,33,728, according to Union health ministry data.
This is also the highest daily rise in the last 83 days. As many as 26,624 new infections were recorded on December 20.
https://timesofindia.indiatimes.com/india/india-to-review-astrazeneca-vaccine-side-effects-after-blood-clot-concerns/articleshow/81481228.cms
This comes in the wake of Denmark, Norway, Iceland and Thailand temporarily halting vaccination with the drug, after isolated
reports of recipients developing blood clots.
"We are looking at all the adverse events, particularly serious adverse events like deaths and hospitalisation. We will come back if we find anything of concern," N.K. Arora, a member of National Task Force on Covid-19, told news agency AFP.
Arora said there was "no immediate issue of concern as number of adverse events (in India) is very, very low. "We are relooking at these to see if there was any issue of blood clotting."
8 States accounted for 74% of the doses, with Uttar Pradesh topping the list with more than 3.3 lakh vaccine doses. Cumulatively, over 2.82 crore doses have been administered so far. India has been using Covishield and Bharat Biotech's Covaxin for its mass vaccination programme.
India’s total active caseload stands at 2.02 lakh . 24,882 new cases were registered in the last 24 hours. India on Saturday recorded 24,882 fresh Covid-19 infections, the highest so far this year, which took the caseload to 1,13,33,728, according to Union health ministry data.
This is also the highest daily rise in the last 83 days. As many as 26,624 new infections were recorded on December 20.
https://timesofindia.indiatimes.com/india/india-to-review-astrazeneca-vaccine-side-effects-after-blood-clot-concerns/articleshow/81481228.cms